Skip to main content

Peer Review reports

From: First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer

Original Submission
14 Nov 2022 Submitted Original manuscript
7 Dec 2022 Reviewed Reviewer Report
20 Dec 2022 Reviewed Reviewer Report
16 Jan 2023 Author responded Author comments - Anhui Shi
Resubmission - Version 2
16 Jan 2023 Submitted Manuscript version 2
20 Jan 2023 Author responded Author comments - Anhui Shi
Resubmission - Version 3
20 Jan 2023 Submitted Manuscript version 3
9 Feb 2023 Reviewed Reviewer Report
17 Feb 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
28 Mar 2023 Editorially accepted
6 Apr 2023 Article published 10.1186/s12885-023-10784-8

You can find further information about peer review here.

Back to article page